Composition of safflower oil and salvia extracts and application thereof
A technology of composition and extract, which is applied in the field of composition and application of safflower oil and salvia miltiorrhiza extract, and can solve the problems of unreported pharmacological activity application
Inactive Publication Date: 2011-03-30
北京科士蓝医药技术有限公司
View PDF0 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0004] The pharmaceutical composition with safflower oil and salvia miltiorrhiza extract (total phenolic acid of salvia miltiorrhiza) as active ingredients and its pharmacological activity or application in treating diseases has not been reported
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] Safflower Oil: Buy; Salvia Extract: Buy.
Embodiment 2
[0016] Preparation of capsules with safflower oil and salvia miltiorrhiza extract as active ingredients
[0017] Take 80g of safflower oil, 80g of salvia miltiorrhiza extract, appropriate amount of starch, mix them evenly, put them in capsules, and you get the product.
Embodiment 3
[0019] Preparation of capsules with safflower oil and salvia miltiorrhiza extract as active ingredients
[0020] Take 40g of safflower oil, 120g of salvia miltiorrhiza extract, appropriate amount of starch, mix well, pack into capsules, and get ready.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention provides a drug composition with safflower oil and salvia extracts as the active ingredients, wherein the content of salvianolic acid B in the salvia extracts is not less than 3%; and the content of linoleic acid in the safflower oil is not less than 50%. The drug composition can be used for treating coronary heart diseases, angina, ischemic cerebral thrombosis, atherosclerosis, myocardial ischemia or myocardial infarction, hyperlipemia, chronic hepatitis b hepatic fibrosis, fatty liver and senile dementia.
Description
technical field [0001] The invention relates to a pharmaceutical composition with safflower oil and salvia miltiorrhiza extract (total salvianolic acid) as active components and a study on its pharmacological activity in cardiovascular and cerebrovascular aspects. Background technique [0002] Safflower oil is made from high-quality safflower seeds, scientifically processed and refined using advanced technology and equipment. It maintains the original nutrients and is rich in natural Ve. As a high-quality edible oil, safflower oil has the highest linoleic acid content among known vegetable oils. It has been confirmed by many scientific research and medical institutions at home and abroad that linoleic acid can prevent human atherosclerosis, reduce blood lipid and serum cholesterol levels, prevent abnormal blood coagulation, soften blood vessels, expand arteries, increase blood circulation, stabilize blood pressure, It improves physical fitness, regulates the heart and endoc...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P1/16A61P3/06A61P7/02A61P9/10
Inventor 郝志忠
Owner 北京科士蓝医药技术有限公司
Features
- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
Why Patsnap Eureka
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com